These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 32487421)

  • 61. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
    Fabbrini G; Fabbrini A; Suppa A
    Handb Clin Neurol; 2019; 165():155-177. PubMed ID: 31727210
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
    Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
    Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Magnetic resonance imaging in progressive supranuclear palsy.
    Stamelou M; Knake S; Oertel WH; Höglinger GU
    J Neurol; 2011 Apr; 258(4):549-58. PubMed ID: 21181185
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vestibular symptoms as the presenting feature of progressive supranuclear palsy.
    Haggstrom L; Brew B; Sutton I; Tisch S
    J Clin Neurosci; 2018 Apr; 50():74-76. PubMed ID: 29398194
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interventions in progressive supranuclear palsy.
    Koros C; Stamelou M
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S93-5. PubMed ID: 26459661
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [
    Schönecker S; Palleis C; Franzmeier N; Katzdobler S; Ferschmann C; Schuster S; Finze A; Scheifele M; Prix C; Fietzek U; Weidinger E; Nübling G; Vöglein J; Patt M; Barthel H; Sabri O; Danek A; Höglinger GU; Brendel M; Levin J;
    Neuroimage Clin; 2023; 38():103402. PubMed ID: 37087820
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy.
    Borroni B; Malinverno M; Gardoni F; Alberici A; Parnetti L; Premi E; Bonuccelli U; Grassi M; Perani D; Calabresi P; Di Luca M; Padovani A
    Neurology; 2008 Nov; 71(22):1796-803. PubMed ID: 18971445
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases.
    Respondek G; Stamelou M; Kurz C; Ferguson LW; Rajput A; Chiu WZ; van Swieten JC; Troakes C; Al Sarraj S; Gelpi E; Gaig C; Tolosa E; Oertel WH; Giese A; Roeber S; Arzberger T; Wagenpfeil S; Höglinger GU;
    Mov Disord; 2014 Dec; 29(14):1758-66. PubMed ID: 25370486
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Progressive supranuclear palsy revisited.
    Litvan I
    Acta Neurol Scand; 1998 Dec; 98(6):73-84. PubMed ID: 9875630
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Creutzfeldt-Jakob disease presenting as progressive supranuclear palsy.
    Josephs KA; Tsuboi Y; Dickson DW
    Eur J Neurol; 2004 May; 11(5):343-6. PubMed ID: 15142229
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Are PSP patients included in clinical trials representative of the general PSP population?
    Mariani LL; Guimarães-Costa R; Grabli D; Le Toullec B; Cormier-Dequaire F; Degos B; Dubois B; Vidailhet M; Lacomblez L; Corvol JC
    Parkinsonism Relat Disord; 2019 Sep; 66():202-206. PubMed ID: 31303434
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Progressive supranuclear palsy.
    Pahwa R
    Med Clin North Am; 1999 Mar; 83(2):369-79, v-vi. PubMed ID: 10093583
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.
    Höglinger GU; Respondek G; Stamelou M; Kurz C; Josephs KA; Lang AE; Mollenhauer B; Müller U; Nilsson C; Whitwell JL; Arzberger T; Englund E; Gelpi E; Giese A; Irwin DJ; Meissner WG; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Antonini A; Bhatia KP; Bordelon Y; Compta Y; Corvol JC; Colosimo C; Dickson DW; Dodel R; Ferguson L; Grossman M; Kassubek J; Krismer F; Levin J; Lorenzl S; Morris HR; Nestor P; Oertel WH; Poewe W; Rabinovici G; Rowe JB; Schellenberg GD; Seppi K; van Eimeren T; Wenning GK; Boxer AL; Golbe LI; Litvan I;
    Mov Disord; 2017 Jun; 32(6):853-864. PubMed ID: 28467028
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [A follow-up study on brainstem atrophy in progressive supranuclear palsy--when does brain MRI contribute to the differential diagnosis between progressive supranuclear palsy and Parkinson disease?].
    Yamamoto T; Oya Y; Ogawa M; Ogata K; Kawai M
    Rinsho Shinkeigaku; 2003 Jul; 43(7):392-7. PubMed ID: 14582364
    [TBL] [Abstract][Full Text] [Related]  

  • 75. PET Tau Imaging and Motor Impairments Differ Between Corticobasal Syndrome and Progressive Supranuclear Palsy With and Without Alzheimer's Disease Biomarkers.
    Vasilevskaya A; Taghdiri F; Multani N; Anor C; Misquitta K; Houle S; Burke C; Tang-Wai D; Lang AE; Fox S; Slow E; Rusjan P; Tartaglia MC
    Front Neurol; 2020; 11():574. PubMed ID: 32754109
    [No Abstract]   [Full Text] [Related]  

  • 76. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
    Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
    J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rho Kinase Inhibition as a Therapeutic for Progressive Supranuclear Palsy and Corticobasal Degeneration.
    Gentry EG; Henderson BW; Arrant AE; Gearing M; Feng Y; Riddle NC; Herskowitz JH
    J Neurosci; 2016 Jan; 36(4):1316-23. PubMed ID: 26818518
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.
    Kurz C; Ebersbach G; Respondek G; Giese A; Arzberger T; Höglinger GU
    Acta Neuropathol Commun; 2016 Nov; 4(1):120. PubMed ID: 27842578
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.